Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck

Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck have?

Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck has 27 citations in the OpenAlex counts ScholarIQ stores.

When was Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck published?

Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck has 2011 year in the ScholarIQ index.

What is the open-access status of Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck?

Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck has closed oa status in the ScholarIQ index.

What is the DOI of Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck?

The DOI for Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck is on the source record.

What is the PMID of Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck?

The PMID for Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck is on the source record.

What is the OpenAlex record for Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck?

The OpenAlex for Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck is on the source record.